Headquartered in Charlotte, NC, Alveolus is a leading developer of non- vascular interventional stent technology. Alveolus' advanced stenting technology enhances the quality of life for patients who suffer from pulmonary or gastrointestinal obstruction. The Alveolus product ideation process, guided by world leading interventionalists, allows for rapid prototyping and development of products to address the specific requirements for each area of the body. Products are created by physicians, for physicians, with an end goal of enhancing the quality of life and reducing the long term medical costs for patients and their families.
Alveolus, Inc. has raised $8.4MM of private equity and is backed by a group of investors including MDS Capital Corp., Matignon Technologies, FCA Venture Partners and MB Ventures.
For more information on Alveolus, Inc., please visit their web site at www.alveolus.com